Shin Jongoh, Lee Namil, Cho Suhyung, Cho Byung-Kwan
Department of Biological Sciences and KI for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
Intelligent Synthetic Biology Center, Daejeon, Republic of Korea.
Methods Mol Biol. 2018;1772:151-169. doi: 10.1007/978-1-4939-7795-6_8.
Recent advances in the CRISPR/Cas9 system have dramatically facilitated genome engineering in various cell systems. Among the protocols, the direct delivery of the Cas9-sgRNA ribonucleoprotein (RNP) complex into cells is an efficient approach to increase genome editing efficiency. This method uses purified Cas9 protein and in vitro transcribed sgRNA to edit the target gene without vector DNA. We have applied the RNP complex to CHO cell engineering to obtain desirable phenotypes and to reduce unintended insertional mutagenesis and off-target effects. Here, we describe our routine methods for RNP complex-mediated gene deletion including the protocols to prepare the purified Cas9 protein and the in vitro transcribed sgRNA. Subsequently, we also describe a protocol to confirm the edited genomic positions using the T7E1 enzymatic assay and next-generation sequencing.
CRISPR/Cas9系统的最新进展极大地促进了各种细胞系统中的基因组工程。在这些方法中,将Cas9-sgRNA核糖核蛋白(RNP)复合物直接导入细胞是提高基因组编辑效率的有效途径。该方法使用纯化的Cas9蛋白和体外转录的sgRNA来编辑靶基因,而无需载体DNA。我们已将RNP复合物应用于CHO细胞工程,以获得理想的表型,并减少意外的插入诱变和脱靶效应。在这里,我们描述了RNP复合物介导的基因缺失的常规方法,包括制备纯化的Cas9蛋白和体外转录的sgRNA的方案。随后,我们还描述了一种使用T7E1酶切分析和下一代测序来确认编辑的基因组位置的方案。